Observation

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2NCT04229979Sellas Life Sciences GroupPhase 3Active not recruiting2025-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.